EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2 Activating Mutations

ChEBI2012-10-12 更新2026-07-21 收录

淋巴瘤靶向治疗

EZH2抑制剂

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-40972 数据链接链接失效反馈

官方服务：

资源简介：

EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2 Activating Mutations

创建时间：

2012-10-12

Activation of AKT induces EZH2-mediated Ã-catenin trimethylation in colorectal cancer. [ChIP-Seq]

结直肠癌分子机制

EZH2抑制剂

The lysine methyltransferase EZH2 is overexpressed in colorectal cancer (CRC) and has been found to be positively and negatively correlated with CRC patient survival depending on the study suggesting

NIAID Data Ecosystem70

Triple combination of BET plus pan-PI3K and NF-?B inhibitors exhibit synergistic activity in adult T cell leukemia/lymphoma

淋巴瘤靶向治疗

天然药物组合

We exploited the use of I-BET762, copanlisib, and bardoxolone methyl inhibitors as triple combination to understand the interactions between these three pathways in Adult T cell leukemia/lymphoma. Ove

NIAID Data Ecosystem50

Effect of SRPK1 inhibitor in ENKTL cells

淋巴瘤靶向治疗

药物机制研究

To explore the effect of SRPK1 inhibitor in ENKTL cells

NIAID Data Ecosystem40

Chidamide inhibits double expressor lymphoma through repressing Myc expression and activity. Chidamide inhibits double expressor lymphoma through repressing Myc expression and activity

淋巴瘤靶向治疗

MYC抑制剂

Double-expressor lymphoma (DEL), defined by MYC and BCL-2 overexpression without corresponding chromosome translocations, is often associated with poor outcomes for standard treatment (R-CHOP). Recent

NIAID Data Ecosystem70

Table_1_The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.XLSX

淋巴瘤靶向治疗

多药耐药逆转

The CD37 targeting radioimmunoconjugate 177Lu-lilotomab satetraxetan (Betalutin) is currently being evaluated in a clinical phase 2b trial for patients with follicular lymphoma (FL) and in a phase 1 t

NIAID Data Ecosystem50

EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2 Activating Mutations

资源简介：

相关数据集